China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report released on Thursday morning. The brokerage issued a hold rating on the stock.

China Pharma Stock Down 3.6 %

CPHI opened at $0.19 on Thursday. China Pharma has a fifty-two week low of $0.17 and a fifty-two week high of $1.16. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.24. The company’s 50-day moving average is $0.23 and its 200 day moving average is $0.24.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.